share_log

盘中速览 | 科指涨约2.2%,科网股普涨,网易、小米涨超3%

Quick overview during the session: The science and technology index rose by about 2.2%, network technology stocks rose across the board, with Netease and Xiaomi up more than 3%.

Futu News ·  Jul 31 10:48

Futu News on July 31st, Hong Kong stock index performed strongly today. As of the time of publication, Hang Seng Index rose 1.42%, State Index rose 1.45%, and Science Index rose 2.23%.

In terms of sectors, network technology stocks are all up, with Ali Health up over 4%, and NetEase, JD Health, and Xiaomi up over 3%. Bilibili, Kuaishou, and Meituan rose more than 2%.

Contract research organizations are strong, with Wuxi Bio up more than 8%, Viva Biotech up 8%, and Tigermed and Wuxi Apptec up more than 7%.

China-affiliated brokerage stocks performed strongly, with Holly Futures up more than 40%, China International Capital Corporation, Guolian Securities, China Galaxy, and Citic Securities up more than 6%.

The semiconductor sector is on the rise, with Shanghai Fudan up more than 3%, Hua Hong Semiconductor and Semiconductor Manufacturing International Corporation (SMIC) up more than 2%.

Electric power stocks fell more than they rose, with Huaneng Power International down more than 6%, CGN Power down more than 3%, and China Huadian Corporation, China Power and other companies down more than 2%.

In terms of individual stocks,$EAST BUY (01797.HK)$East Buy rose more than 8%. BOCOM International stated that the sale of Dongfang Zhenxuan and Huitongxing will impact short-term GMV and profits.

$JIUMAOJIU (09922.HK)$Up more than 6%, the company's subsidiary Tai'er Pickled Fish has reached a strategic cooperation with Meituan, and plans to open 50 satellite stores for the brand within the year.

$DZUG (01635.HK)$Down more than 13%, it initially rose nearly 19%. The company announced yesterday that the market is paying close attention to intelligent-connected autos recently, and the model is still in the experimental stage and does not generate much revenue.

$CUTIA-B (02487.HK)$Up more than 10%, CU-30101 drug has been accepted for listing application.

$PRADA (01913.HK)$Opened high and fell, now the increase has narrowed to about 3%. Mid-term performance exceeded expectations, and CICC's target price is expected to be as high as HKD 75.

Editor/Jeffy

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment